Download video

Avelumab and axitinib for the treatment of advanced RCC

112 views

VJOncology

7 years ago

Avelumab and axitinib for the treatment of advanced RCC

Avelumab and axitinib for the treatment of advanced RCC

Avelumab and axitinib for the treatment of advanced RCC
0:57
Avelumab and axitinib for the treatment of advanced RCC
by VJOncology
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
4:39
Avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
by ecancer
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
9:30
Study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
by ecancer
Real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
0:44
Real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
by VJOncology
Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trial
1:24
Final results of avelumab and axitinib in RCC in the JAVELIN Renal 101 trial
by VJOncology
Avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
2:32
Avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
by infocusrx today
Combining avelumab and axitinib in advanced renal cell carcinoma (RCC)
2:27
Combining avelumab and axitinib in advanced renal cell carcinoma (RCC)
by VJOncology
Dr. McGregor on the Utility of Axitinib\/Avelumab in Advanced RCC
1:06
Dr. McGregor on the Utility of Axitinib\/Avelumab in Advanced RCC
by OncLive
Pembrolizumab\/Axitinib and Avelumab\/Axitinib combo for RCC
1:00
Pembrolizumab\/Axitinib and Avelumab\/Axitinib combo for RCC
by VJOncology
Dr. Choueiri Discusses Avelumab\/Axitinib Data in RCC
1:47
Dr. Choueiri Discusses Avelumab\/Axitinib Data in RCC
by OncLive
Exploring the Combination of First-Line Avelumab\/Axitinib in HCC
3:18
Exploring the Combination of First-Line Avelumab\/Axitinib in HCC
by Targeted Oncology
Avelumab plus axitinib shows good efficacy for OS and PFS in aRCC patients
0:47
Avelumab plus axitinib shows good efficacy for OS and PFS in aRCC patients
by VJOncology
JAVELIN Renal 101: avelumab plus axitinib improve PFS for advanced renal cell cancer
9:23
JAVELIN Renal 101: avelumab plus axitinib improve PFS for advanced renal cell cancer
by VJOncology
Immunotherapy Combinations Improve Survival in Advanced Renal Cell Carcinoma
1:37
Immunotherapy Combinations Improve Survival in Advanced Renal Cell Carcinoma
by Targeted Oncology
Dr. Choueiri on Avelumab Plus Axitinib in mRCC
1:38
Dr. Choueiri on Avelumab Plus Axitinib in mRCC
by OncLive
Dr. Shuch on Caveats of Avelumab\/Axitinib Combination in RCC
1:37
Dr. Shuch on Caveats of Avelumab\/Axitinib Combination in RCC
by OncLive
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC
3:22
Biomarker analysis from JAVELIN Renal 101: Avelumab plus axitinib versus sunitinib in aRCC
by ecancer
Prof Jon Haanan on the JAVELIN study
4:48
Prof Jon Haanan on the JAVELIN study
by ecancer
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC
1:17
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC
by OncLive
Phase I\/II study of nivolumab and axitinib for advanced RCC
1:29
Phase I\/II study of nivolumab and axitinib for advanced RCC
by VJOncology